نتائج البحث

Continuous versus intermittent infusion of β-lactams in patients with sepsis and septic shock: a systematic review and meta-analysis.

• Authors : Tejada DA; National Institute of Health, San Salvador, El Salvador.; García HC

Subjects: beta-Lactams*/beta-Lactams*/beta-Lactams*/administration & dosage ; beta-Lactams*/beta-Lactams*/beta-Lactams*/therapeutic use ; Shock, Septic*/Shock, Septic*/Shock, Septic*/drug therapy

• Source: BMC infectious diseases [BMC Infect Dis] 2025 Sep 26; Vol. 25 (1), pp. 1138. Date of Electronic Publication: 2025 Sep 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Comparative evaluation of five β-Lactamase inhibitors in combination with β-Lactams against multidrug-resistant Mycobacterium tuberculosis in vitro.

• Authors : Shi J; Henan Province Center for Disease Control and Prevention, Zhengzhou City, Henan Province, China. .; Zheng D

Subjects: Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/drug effects ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/genetics ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/isolation & purification

• Source: BMC infectious diseases [BMC Infect Dis] 2025 Apr 28; Vol. 25 (1), pp. 619. Date of Electronic Publication: 2025 Apr 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study.

• Authors : Aldardeer NF; Critical Care Clinical Pharmacy Consultant, Medical and Clinical Affairs Department, King Faisal Specialist Hospital and Research Center, P.O. Box 40047, Jeddah, 21499, Saudi Arabia. .; Labban HM

Subjects: Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects ; Pseudomonas Infections*/Pseudomonas Infections*/Pseudomonas Infections*/drug therapy ; Pseudomonas Infections*/Pseudomonas Infections*/Pseudomonas Infections*/microbiology

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Dec 22; Vol. 24 (1), pp. 1455. Date of Electronic Publication: 2024 Dec 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Efficacy and safety analysis of lorlatinib for ALK-positive advanced NSCLC: a multicentre real-world study in China.

• Authors : Chen Z; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, China.; Tang C

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics

• Source: BMC cancer [BMC Cancer] 2025 Jul 25; Vol. 25 (1), pp. 1216. Date of Electronic Publication: 2025 Jul 25.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

IncI2 plasmid transfer and changes of intestinal microbiota in mice under β-lactam antibiotic pressure.

• Authors : Liu K; National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou, P. R. China.; Liu J

Subjects: Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/drug effects ; Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/genetics ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology

• Source: BMC veterinary research [BMC Vet Res] 2025 May 15; Vol. 21 (1), pp. 343. Date of Electronic Publication: 2025 May 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101249759 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study.

• Authors : Ewoldt TMJ; Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. .; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands. .

Subjects: Drug Monitoring* ; beta-Lactams*/beta-Lactams*/beta-Lactams*/therapeutic use; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/therapeutic use

• Source: BMC infectious diseases [BMC Infect Dis] 2022 Jul 13; Vol. 22 (1), pp. 611. Date of Electronic Publication: 2022 Jul 13.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial.

• Authors : Horstink MMB; BULLSEYE investigators

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/administration & dosage ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use ; beta-Lactams*/beta-Lactams*/beta-Lactams*/administration & dosage

• Source: BMC infectious diseases [BMC Infect Dis] 2025 Mar 21; Vol. 25 (1), pp. 392. Date of Electronic Publication: 2025 Mar 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

A plug-and-play system for polycyclic tetramate macrolactam production and functionalization.

• Authors : Glöckle A; Chair of Technical Biochemistry, Technische Universität Dresden, Bergstraße 66, 01069, Dresden, Germany.; Schuler S

Subjects: Streptomyces*/Streptomyces*/Streptomyces*/metabolism ; Streptomyces*/Streptomyces*/Streptomyces*/genetics ; Lactams, Macrocyclic*/Lactams, Macrocyclic*/Lactams, Macrocyclic*/metabolism

• Source: Microbial cell factories [Microb Cell Fact] 2025 Jan 10; Vol. 24 (1), pp. 13. Date of Electronic Publication: 2025 Jan 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101139812 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Diversity-oriented synthesis and activity evaluation of substituted bicyclic lactams as anti-malarial against Plasmodium falciparum.

• Authors : Sharma, Vijeta¹ ; Agarwal, Shalini² ; Madurkar, Sanjay M.³

• Source: Malaria Journal. 2014, Vol. 13 Issue 1, p1-20. 20p. 4 Graphs.

تفاصيل العنوان

Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease.

• Authors : Colaneri M; Department of Infectious Diseases, Unit II, L. Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.

Subjects: SARS-CoV-2* ; COVID-19* ; Lactams*

• Source: Virology journal [Virol J] 2024 Mar 20; Vol. 21 (1), pp. 68. Date of Electronic Publication: 2024 Mar 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium:

تفاصيل العنوان